354 related articles for article (PubMed ID: 22952952)
41. Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib.
Tsai AC; Wang CY; Liou JP; Pai HC; Hsiao CJ; Chang JY; Wang JC; Teng CM; Pan SL
Cell Death Dis; 2014 Apr; 5(4):e1162. PubMed ID: 24722287
[TBL] [Abstract][Full Text] [Related]
42. Microtubule-dependent changes in assembly of microtubule motor proteins and mitotic spindle checkpoint proteins at PtK1 kinetochores.
Hoffman DB; Pearson CG; Yen TJ; Howell BJ; Salmon ED
Mol Biol Cell; 2001 Jul; 12(7):1995-2009. PubMed ID: 11451998
[TBL] [Abstract][Full Text] [Related]
43. C1, a highly potent novel curcumin derivative, binds to tubulin, disrupts microtubule network and induces apoptosis.
Srivastava S; Mishra S; Surolia A; Panda D
Biosci Rep; 2016; 36(2):. PubMed ID: 26980197
[TBL] [Abstract][Full Text] [Related]
44. hNuf2 inhibition blocks stable kinetochore-microtubule attachment and induces mitotic cell death in HeLa cells.
DeLuca JG; Moree B; Hickey JM; Kilmartin JV; Salmon ED
J Cell Biol; 2002 Nov; 159(4):549-55. PubMed ID: 12438418
[TBL] [Abstract][Full Text] [Related]
45. Dietary flavonoid fisetin binds to β-tubulin and disrupts microtubule dynamics in prostate cancer cells.
Mukhtar E; Adhami VM; Sechi M; Mukhtar H
Cancer Lett; 2015 Oct; 367(2):173-83. PubMed ID: 26235140
[TBL] [Abstract][Full Text] [Related]
46. The kinetics of p53 activation versus cyclin E accumulation underlies the relationship between the spindle-assembly checkpoint and the postmitotic checkpoint.
Chan YW; On KF; Chan WM; Wong W; Siu HO; Hau PM; Poon RY
J Biol Chem; 2008 Jun; 283(23):15716-23. PubMed ID: 18400748
[TBL] [Abstract][Full Text] [Related]
47. Anticancer activity of a novel small molecule tubulin inhibitor STK899704.
Sakchaisri K; Kim SO; Hwang J; Soung NK; Lee KH; Choi TW; Lee Y; Park CM; Thimmegowda NR; Lee PY; Shwetha B; Srinivasrao G; Pham TT; Jang JH; Yum HW; Surh YJ; Lee KS; Park H; Kim SJ; Kwon YT; Ahn JS; Kim BY
PLoS One; 2017; 12(3):e0173311. PubMed ID: 28296906
[TBL] [Abstract][Full Text] [Related]
48. MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27.
Pai HC; Kumar S; Shen CC; Liou JP; Pan SL; Teng CM
PLoS One; 2015; 10(4):e0123819. PubMed ID: 25874627
[TBL] [Abstract][Full Text] [Related]
49. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
[TBL] [Abstract][Full Text] [Related]
50. 1,3,4-oxadiazole-2-thione Derivatives; Novel Approach for Anticancer and Tubulin Polymerization Inhibitory Activities.
Abdel-Aziz M; Metwally KA; Gamal-Eldeen AM; Aly OM
Anticancer Agents Med Chem; 2015; 16(2):269-77. PubMed ID: 26343141
[TBL] [Abstract][Full Text] [Related]
51. Ferulin C triggers potent PAK1 and p21-mediated anti-tumor effects in breast cancer by inhibiting Tubulin polymerization in vitro and in vivo.
Yao D; Pan D; Zhen Y; Huang J; Wang J; Zhang J; He Z
Pharmacol Res; 2020 Feb; 152():104605. PubMed ID: 31863866
[TBL] [Abstract][Full Text] [Related]
52. CXI-benzo-84 reversibly binds to tubulin at colchicine site and induces apoptosis in cancer cells.
Rai A; Gupta TK; Kini S; Kunwar A; Surolia A; Panda D
Biochem Pharmacol; 2013 Aug; 86(3):378-91. PubMed ID: 23747346
[TBL] [Abstract][Full Text] [Related]
53. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
[TBL] [Abstract][Full Text] [Related]
54. Up-regulation of the mitotic checkpoint component Mad1 causes chromosomal instability and resistance to microtubule poisons.
Ryan SD; Britigan EM; Zasadil LM; Witte K; Audhya A; Roopra A; Weaver BA
Proc Natl Acad Sci U S A; 2012 Aug; 109(33):E2205-14. PubMed ID: 22778409
[TBL] [Abstract][Full Text] [Related]
55. Stabilization of microtubule dynamics by estramustine by binding to a novel site in tubulin: a possible mechanistic basis for its antitumor action.
Panda D; Miller HP; Islam K; Wilson L
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10560-4. PubMed ID: 9380674
[TBL] [Abstract][Full Text] [Related]
56. Investigation of anti-tumor mechanisms of K2154: characterization of tubulin isotypes, mitotic arrest and apoptotic machinery.
Lu PH; Kung FL; Kuo SC; Chueh SC; Guh JH
Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):223-33. PubMed ID: 17102938
[TBL] [Abstract][Full Text] [Related]
57. Cells satisfy the mitotic checkpoint in Taxol, and do so faster in concentrations that stabilize syntelic attachments.
Yang Z; Kenny AE; Brito DA; Rieder CL
J Cell Biol; 2009 Sep; 186(5):675-84. PubMed ID: 19720871
[TBL] [Abstract][Full Text] [Related]
58. Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitor.
Hsu LC; Durrant DE; Huang CC; Chi NW; Baruchello R; Rondanin R; Rullo C; Marchetti P; Grisolia G; Simoni D; Lee RM
Invest New Drugs; 2012 Aug; 30(4):1379-88. PubMed ID: 21655917
[TBL] [Abstract][Full Text] [Related]
59. Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability.
Smith JA; Wilson L; Azarenko O; Zhu X; Lewis BM; Littlefield BA; Jordan MA
Biochemistry; 2010 Feb; 49(6):1331-7. PubMed ID: 20030375
[TBL] [Abstract][Full Text] [Related]
60. Vitamin K3 disrupts the microtubule networks by binding to tubulin: a novel mechanism of its antiproliferative activity.
Acharya BR; Choudhury D; Das A; Chakrabarti G
Biochemistry; 2009 Jul; 48(29):6963-74. PubMed ID: 19527023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
